| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 9 | +66.67% | +2.23% | +0.84% | +1.39% | -3.38% | — |
| 14d | 9 | +22.22% | +4.73% | +1.31% | +3.42% | +5.21% | — |
| 30d | 9 | +33.33% | +8.40% | +2.48% | +5.92% | +2.35% | — |
| 60d | 9 | +33.33% | +19.91% | +3.50% | +16.41% | +2.69% | — |
| 90d | 9 | +33.33% | +23.10% | +6.12% | +16.98% | +9.63% | — |
| 180d | 9(2 pending) | +71.43% | +37.51% | +9.11% | +28.40% | -24.31% | — |
| 1y | 9(6 pending) | +33.33% | +54.74% | +23.83% | +30.91% | +20.39% | — |
| 2y | 9(7 pending) | +100.00% | -47.51% | +43.77% | -91.28% | -91.28% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Legal Officer | 11,824 | $3.16 | $37.3K | 667,524 | Jun 17, 2026 | Jun 18, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Legal Officer | 5,708 | $2.70 | $15.4K | 679,348 | Mar 17, 2026 | Mar 18, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,840 | — | — | 685,056 | Mar 13, 2026 | Mar 16, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 269,230 | — | — | 269,230 | Mar 13, 2026 | Mar 16, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE General Counsel | 1,689 | $2.88 | $4.9K | 384,216 | Jan 20, 2026 | Jan 21, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE General Counsel | 6,517 | $3.67 | $23.9K | 385,905 | Dec 17, 2025 | Dec 18, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE General Counsel | 1,248 | $2.62 | $3.3K | 392,422 | Oct 17, 2025 | Oct 20, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE General Counsel | 6,267 | $2.80 | $17.6K | 393,670 | Sep 17, 2025 | Sep 18, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE General Counsel | 1,304 | $1.13 | $1.5K | 399,937 | Jul 17, 2025 | Jul 18, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE General Counsel | 6,422 | $1.15 | $7.4K | 401,241 | Jun 17, 2025 | Jun 18, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 224,000 | — | — | 407,663 | Mar 14, 2025 | Mar 17, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 201,000 | — | — | 201,000 | Mar 14, 2025 | Mar 17, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 183,663 | Mar 14, 2024 | Mar 15, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Mar 14, 2024 | Mar 15, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE General Counsel | 1,290 | $1.27 | $1.6K | 83,663 | Apr 19, 2023 | Apr 20, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,500 | — | — | 84,953 | Mar 14, 2023 | Mar 15, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 86,900 | — | — | 86,900 | Mar 14, 2023 | Mar 15, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE General Counsel | 6,347 | $7.00 | $44.4K | 64,453 | Jan 18, 2023 | Jan 19, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 52,000 | — | — | 52,000 | Jun 7, 2022 | Jun 9, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,450 | — | — | 100,450 | Jan 27, 2022 | Jan 28, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,800 | — | — | 70,800 | Jan 27, 2022 | Jan 28, 2022 ↗ | View → |